Abstract
After our initial report tha leukocyte dialysates containing transfer factor augment the thymidine incorporation of antigen-stimulated lymphocytes, we have adapted the system to microleukocyte cultures. This modification permits both (a) the simultaneous assay of a single dialysate on the cells of multiple individuals, and (b) the assay of multiple dialysates on the cells of a single individual. The data thus secured, demonstrate that dialysates from both skin-test-positive and - negative donors produced similar degrees of augmentation whether the data are expressed as an arithmetic difference or as a ratio. When expressed as an arithmetic difference, the amount of augmentation is increased in proportion to the level of thymidine incorporation of the assay cells when they were stimulated by antigen alone. When expressed as a ratio, however, the degree of augmentation is independent of the response of the assay cells. An analysis of the ability of dialysates to engage previously uncommitted lymphocytes and thus to augment thymidine incorporation, revealed that precommitted cells were required. In these experiments, antigen-reactive cells were deleted from populations of peripheral blood lymphocytes by incubation with purified protein derivative of tuberculin, diphtheria toxoid, or streptokinase-streptodornase in the presence of [3H]thymidine of high specific activity. This deletion depressed or abolished the effect of dialysate on the residual population when it was recultured with the same antigen, but the effect on the response of the remaining lymphocytes to other antigens was unaltered. In this study, leukocyte dialysate appeared to augment nonspecifically the thymidine incorporation of an antigen-specific precommitted clone of lymphocytes. The relationship of these adjuvant effects on peripheral blood lymphocytes in vitro to the specific and nonspecific activities of transfer factor in vivo remains to be elucidated.
Full Text
The Full Text of this article is available as a PDF (895.5 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Arala-Chaves M., Ramos M. T., Rosado R., Branco P. Transfer factor in vitro. Additional data concerning a new method. Int Arch Allergy Appl Immunol. 1974;46(4):612–618. [PubMed] [Google Scholar]
- Ascher M. S., Schneider W. J., Valentine F. T., Lawrence H. S. In vitro properties of leukocyte dialysates containing transfer factor. Proc Natl Acad Sci U S A. 1974 Apr;71(4):1178–1182. doi: 10.1073/pnas.71.4.1178. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brandes L. J., Goldenberg G. J. In vitro transfer of cellular immunity against nasopharyngeal carcinoma using transfer factor from donors with Epstein-Barr virus antibody activity. Cancer Res. 1974 Nov;34(11):3095–3101. [PubMed] [Google Scholar]
- Diamantstein T., Ulmer A. The antagonistic action of cyclic GMP and cyclic AMP on proliferation of B and T lymphocytes. Immunology. 1975 Jan;28(1):113–119. [PMC free article] [PubMed] [Google Scholar]
- Dutton R. W., Mishell R. I. Cell populations and cell proliferation in the in vitro response of normal mouse spleen to heterologous erythrocytes. Analysis by the hot pulse technique. J Exp Med. 1967 Sep 1;126(3):443–454. doi: 10.1084/jem.126.3.443. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hirschberg H., Thorsby E. Specific in vitro elimination of histocompatibility antigen reactive cells (HARC). J Immunol Methods. 1973 Nov;3(3):251–263. doi: 10.1016/0022-1759(73)90021-5. [DOI] [PubMed] [Google Scholar]
- Lawrence H. S. Transfer factor in cellular immunity. Harvey Lect. 1974;68:239–350. [PubMed] [Google Scholar]
- Lawrence H. S. Transfer factor. Adv Immunol. 1969;11:195–266. doi: 10.1016/s0065-2776(08)60480-0. [DOI] [PubMed] [Google Scholar]
- Lawrence H. S., Valentine F. T. Transfer factor in delayed hypersensitivity. Ann N Y Acad Sci. 1970 Feb 13;169(1):269–287. doi: 10.1111/j.1749-6632.1970.tb55996.x. [DOI] [PubMed] [Google Scholar]
- Palmer D. W., Smith R. T. Augmentation of PPD- and LPS-induced T-independent DNA synthesis in normal mouse spleen cells by leukocyte lysates from tuberculosis patients. Cell Immunol. 1974 Aug;13(2):196–206. doi: 10.1016/0008-8749(74)90238-x. [DOI] [PubMed] [Google Scholar]
- Read S. E., Zabriskie J. B. Cellular interactions in the leukocyte migration inhibition system. Transplant Proc. 1972 Jun;4(2):247–252. [PubMed] [Google Scholar]
- Sandler J. A., Smith T. K., Manganiello V. C., Kirkpatrick C. H. Stimulation of monocyte cGMP by leukocyte dialysates. An antigen-independent property of dialyzable transfer factor. J Clin Invest. 1975 Nov;56(5):1271–1279. doi: 10.1172/JCI108203. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Soborg M., Bendixen G. Human lymphocyte migration as a parameter of hypersensitivity. Acta Med Scand. 1967 Feb;181(2):247–256. doi: 10.1111/j.0954-6820.1967.tb07255.x. [DOI] [PubMed] [Google Scholar]
- Utermohlen V., Zabriskie J. B. A suppression of cellular immunity in patients with multiple sclerosis. J Exp Med. 1973 Dec 1;138(6):1591–1596. doi: 10.1084/jem.138.6.1591. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Watson J., Epstein R., Cohn M. Cyclic nucleotides as intracellular mediators of the expression of antigen-sensitive cells. Nature. 1973 Dec 14;246(5433):405–409. doi: 10.1038/246405a0. [DOI] [PubMed] [Google Scholar]
- Webb D. R., Belohradsky B., Hanes D., Stites D. P., Perlman J. D., Fudenberg H. H. Control of mitogen-induced lymphocyte activation. 11. Analysis of cell populations and metabolic events involved in cyclic AMP-mediated recovery of DNA synthesis suppressed by mitogens. Clin Immunol Immunopathol. 1975 Jul;4(2):226–240. doi: 10.1016/0090-1229(75)90058-6. [DOI] [PubMed] [Google Scholar]
- Ziegler J. B., Hansen P. J., Davies W. A., Penny R. The PHA dose-response curve: validation of the use of logarithmic graph paper by computer analysis results. J Immunol. 1974 Dec;113(6):2035–2039. [PubMed] [Google Scholar]